Morgan Stanley slashed its price target on Moderna Inc (BMV:MRNA) (NASDAQ:MRNA) to $38 from $70 given the lowered revenue guidance and ongoing competitive pressures in the vaccine market.
Annemarie Hanekamp has overseen some of the most transformative changes in oncology over her years in Big Pharma. Now, she ...
Moderna (NASDAQ: MRNA) was one of the hottest companies of early pandemic times, delivering a coronavirus vaccine to market ...
Moderna (NASDAQ: MRNA) shareholders have been having a rough time lately. The biotech stock rocketed higher last spring, but ...
Korea Joongang Daily on MSN13h
Gov’t urges vaccinations before Lunar New Year as immunity wanes and variants emergeThe government is urging the public to get vaccinated against influenza and Covid-19 before the Lunar New Year holiday, which ...
We recently published a list of 11 Stocks That Will Go to the Moon According to Reddit. In this article, we are going to take ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback